Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



Agreement between parents? and clinical researchers? ratings of behavioral problems in children with fragile X syndrome and chromosome 15 imprinting disorders
Indexado
WoS WOS:000868200200001
Scopus SCOPUS_ID:85138789482
DOI 10.1016/J.RIDD.2022.104338
Año 2022
Tipo artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



Background: Despite the increasing number of clinical trials involving children with neurodevelopmental disorders, appropriate and objective outcome measures for behavioral symptoms are still required.Aim: This study assessed the agreement between parents' and clinical researchers' ratings of behavioral problem severity in children with fragile X syndrome (FXS) and chromosome 15 imprinting disorders.Methods and Procedures: The cohort comprised 123 children (64% males), aged 3-17 years, with FXS (n = 79), Prader-Willi (PWS; n = 19), Angelman (AS; n = 15), and Chromosome 15q duplication (n = 10) syndromes. Specific items from the Autism Diagnostic Observation ScheduleSecond Edition and Aberrant Behavior Checklist-Community Edition mapping to corresponding behavioral domains were selected ad-hoc, to assess behavioral problems. Outcomes and Results: Inter-rater agreement for the cohort was slight for self-injury (Intraclass Correlation Coefficient (ICC) = 0.12), fair for tantrums/aggression (0.24) and mannerisms/stereotypies (0.25), and moderate for hyperactivity (0.48). When stratified by diagnosis, ICC ranged from poor (0; self-injury, AS and PWS) to substantial (0.48; hyperactivity, females with FXS).Conclusions and Implications: The high level of inter-rater disagreement across most domains suggests that parents' and researchers' assessments led to discrepant appraisal of behavioral problem severity. These findings have implications for treatment targets and outcome measure selection in clinical trials, supporting a multi-informant approach.

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Education, Special
Rehabilitation
Scopus
Clinical Psychology
Developmental And Educational Psychology
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 Arpone, Marta Mujer Royal Childrens Hosp - Australia
Univ Melbourne - Australia
Royal Children's Hospital, Melbourne - Australia
Faculty of Medicine, Dentistry and Health Sciences - Australia
2 Bretherton, Lesley - Royal Childrens Hosp - Australia
Royal Children's Hospital, Melbourne - Australia
3 Amor, D. Hombre Univ Melbourne - Australia
Royal Childrens Hosp - Australia
Faculty of Medicine, Dentistry and Health Sciences - Australia
Royal Children's Hospital, Melbourne - Australia
4 Hearps, Stephen J. C. Hombre Royal Childrens Hosp - Australia
Univ Melbourne - Australia
Royal Children's Hospital, Melbourne - Australia
Faculty of Medicine, Dentistry and Health Sciences - Australia
5 Rogers, Carolyn Mujer Genet Learning Disabil Serv - Australia
Hunter Health - Australia
6 Field, Michael J. Hombre Genet Learning Disabil Serv - Australia
Hunter Health - Australia
7 Hunter, Matthew F. Hombre Monash Hlth - Australia
MONASH UNIV - Australia
Monash Health - Australia
Faculty of Medicine, Nursing and Health Sciences - Australia
Faculty of Medicine, Dentistry and Health Sciences - Australia
8 SANTA MARIA-VASQUEZ, LORENA IVETTE Mujer Universidad de Chile - Chile
9 Alliende, Angelica M. Mujer Universidad de Chile - Chile
10 Slee, Jennie Mujer Govt Western Australia - Australia
Government of Western Australia - Australia
11 Godler, David E. Hombre Royal Childrens Hosp - Australia
Univ Melbourne - Australia
Royal Children's Hospital, Melbourne - Australia
Faculty of Medicine, Dentistry and Health Sciences - Australia
12 Baker, Emma K. Mujer Royal Childrens Hosp - Australia
Univ Melbourne - Australia
La Trobe Univ - Australia
Murdoch Childrens Res Inst - Australia
Royal Children's Hospital, Melbourne - Australia
Faculty of Medicine, Dentistry and Health Sciences - Australia
La Trobe University - Australia

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento



Fuente
University of Melbourne
National Health and Medical Research Council
NHMRC
Victorian Government's Operational Infrastructure Support Program
Diagnosis and Development group of the Murdoch Children's Research Institute
Royal Children's Hospital Foundation
Financial Markets Foundation for Children (Australia)
Genetics of Learning Disability (GOLD) Service
International Postgraduate Research Scholarships (IPRS)
Murdoch Children's Research Institute
Medical Research Future Fund
Financial Markets Foundation for Children
Australian Postgraduate Award
State Government of Victoria
Murdoch Children's Research Institute, Royal Children's Hospital Foundation
Next Generation Clinical Researchers Program-Career Development Fellowship - Medical Research Future Fund
Foundation for Angelman Syndrome Therapeutics
Foundation for Prader-Willi Research (FPWR)
Foundation for Angelman Syndrome Therapeutics (FAST; Australia)
Research Training Program Fee offset scholarship - University of Melbourne
Foundation for Prader-Willi Research

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
This study was supported by the Victorian Government's Operational Infrastructure Support Program, with the salaries supported by NHMRC project grants (1049299, 1103389 to D.E.G); Murdoch Children's Research Institute, Royal Children's Hospital Foundation (D.E.G.); Next Generation Clinical Researchers Program-Career Development Fellowship, funded by the Medical Research Future Fund (MRF1141334 to D.E.G.); the Financial Markets Foundation for Children (Australia) (no. 2017 - 361 to D.E.G. and D.J.A.); the Foundation for Angelman Syndrome Therapeutics (FAST; Australia to E.K.B.); and the Foundation for Prader-Willi Research (FPWR to D.E.G., D.J.A and E.K.B.). M.J.F. and C.R. were supported by the Genetics of Learning Disability (GOLD) Service. M.A. was supported by an Australian Postgraduate Award, the International Postgraduate Research Scholarships (IPRS) and the Research Training Program Fee offset scholarship awarded by the University of Melbourne, and in part by the Diagnosis and Development group of the Murdoch Children's Research Institute.
This study was supported by the Victorian Government’s Operational Infrastructure Support Program , with the salaries supported by NHMRC project grants ( 1049299 , 1103389 to D.E.G); Murdoch Children’s Research Institute, Royal Children’s Hospital Foundation (D.E.G.); Next Generation Clinical Researchers Program-Career Development Fellowship, funded by the Medical Research Future Fund ( MRF1141334 to D.E.G.); the Financial Markets Foundation for Children (Australia) (no. 2017 – 361 to D.E.G. and D.J.A.); the Foundation for Angelman Syndrome Therapeutics (FAST; Australia to E.K.B.); and the Foundation for Prader-Willi Research (FPWR to D.E.G., D.J.A and E.K.B.). M.J.F. and C.R. were supported by the Genetics of Learning Disability (GOLD) Service. M.A. was supported by an Australian Postgraduate Award , the International Postgraduate Research Scholarships (IPRS) and the Research Training Program Fee offset scholarship awarded by the University of Melbourne, and in part by the Diagnosis and Development group of the Murdoch Children’s Research Institute.

Muestra la fuente de financiamiento declarada en la publicación.